Clinical trial
STD Risk Reduction for Heterosexual Methamphetamine Users
NCT00344214 · University of California, San Diego, Other · Completed
Key facts
| NCT number | NCT00344214 |
|---|---|
| Title | STD Risk Reduction for Heterosexual Methamphetamine Users |
| Official title | Reducing HIV/STD Risk, Methamphetamine Use, and Depression Among Heterosexuals |
| Lead sponsor | University of California, San Diego, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Substance-Related Disorders, HIV Infections, Sexually Transmitted Diseases |
| Intervention type | Behavioral |
| Interventions | Tri-focal cognitive behavioral therapy - social skills training (CBTSS) counseling program, Standard care |
| Enrollment | 432 |
| Start date | Oct 1, 2006 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Jun 26, 2006 |
| Last update posted | Sep 28, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: